LOADING
Comparing Johnson & Johnson (JNJ) and Comcast Corporation (CMCSA) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | CMCSA |
|---|---|---|
| Price | $227.50 | $27.56 |
| Change Today | -1.37% | -12.90% |
| Market Cap | $555.2B | $115.3B |
| P/E Ratio | 26.7 | 6.2 |
| Forward P/E | 20.0 | 8.6 |
| PEG Ratio | 3.01 | 142.98 |
| EPS | $8.63 | $5.10 |
| Revenue Growth (YoY) | 9.9% | 1.2% |
| Profit Margin | 21.8% | 16.2% |
| Return on Equity | 35.0% | 21.4% |
| Dividend Yield | 2.30% | -- |
| Beta | 0.33 | 0.79 |
| 52-Week High | $251.71 | $32.98 |
| 52-Week Low | $142.16 | $23.58 |
| Volume | 6.1M | 65.5M |
Johnson & Johnson is the larger company by market capitalization. Comcast Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.